Company: CMND
Filing Date: 2025-11-17
Form Type: 424B5
Source: 0001213900-25-111233
Chunk: 63

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-17
Form: 424B5
Chunk 63
---
 the SEC.

<div align='center'>PLAN OF DISTRIBUTION</div>

The securities being offered by this prospectus may be sold:

| ● | through 
 agents; |

| ● | to or                                                                  
 through one or more underwriters on a firm commitment or agency basis; |

| ● | through                                                     
 put or call option transactions relating to the securities; |

| ● | to or                                                                                                                                   
 through dealers, who may act as agents or principals, including a block trade (which may involve crosses) in which a broker or dealer   
 so engaged will attempt to sell as agent but may position and resell a portion of the block as principal to facilitate the transaction; |

| ● | through                            
 privately negotiated transactions; |

| ● | purchases                                                                                                               
 by a broker or dealer as principal and resale by such broker or dealer for its own account pursuant to this prospectus; |

| ● | directly                                                                                                                          
 to purchasers, including our affiliates, through a specific bidding or auction process, on a negotiated basis or otherwise; to or 
 through one or more underwriters on a firm commitment or best efforts basis;                                                      |

<div align='center'>24</div>

| ● | exchange                                      
 distributions and/or secondary distributions; |

| ● | ordinary                                                                         
 brokerage transactions and transactions in which the broker solicits purchasers; |

| ● | in “at-the-market”                                                                                                                     
 offerings, within the meaning of Rule 415(a)(4) of the Securities Act to or through a market maker or into an existing trading market, 
 on an exchange or otherwise;                                                                                                           |

| ● | transactions                                                                                                             
 not involving market makers or established trading markets, including direct sales or privately negotiated transactions; |

| ● | transactions                                                                           
 in options, swaps or other derivatives that may or may not be listed on an exchange or |

| ● | through                                                   
 any other method permitted pursuant to applicable law; or |

| ● | through                                    
 a combination of any such methods of sale. |

At any time a particular offer of the securities covered by this prospectus is made, a revised prospectus or prospectus supplement, if required, will be distributed which will set forth the aggregate amount of securities covered by this prospectus being offered and the terms of the offering, including the name or names of any underwriters, dealers, brokers or agents, any discounts, commissions, concessions and other items constituting compensation from us and any discounts, commissions or concessions allowed or re-allowed or paid to dealers. Such prospectus supplement, and,